The First-in-human Study of SRN-001 in Healthy Participants

NCT05984992 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: SRN-001
DRUG: Placebo

Sponsor

siRNAgen Therapeutics Inc.